Norveška -
norveščina -
Statens legemiddelverk
rimactan 300 mg
sandoz gmbh - rifampicin - kapsel, hard - 300 mg
Norveška -
norveščina -
Statens legemiddelverk
rimactan 300 mg
2care4 aps - rifampicin - kapsel, hard - 300 mg
Norveška -
norveščina -
Statens legemiddelverk
rimcure
sandoz - københavn - rifampicin / isoniazid / pyrazinamid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg
Norveška -
norveščina -
Statens legemiddelverk
rimstar
2care4 aps - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
Norveška -
norveščina -
Statens legemiddelverk
micardis 40 mg
orifarm as - telmisartan - tablett - 40 mg
Norveška -
norveščina -
Statens legemiddelverk
micardis 80 mg
orifarm as - telmisartan - tablett - 80 mg
Norveška -
norveščina -
Statens legemiddelverk
rimactan 300 mg
orifarm as - rifampicin - kapsel, hard - 300 mg
Evropska unija -
norveščina -
EMA (European Medicines Agency)
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale midler til systemisk bruk - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
Norveška -
norveščina -
Statens legemiddelverk
micardis 80 mg
2care4 aps - telmisartan - tablett - 80 mg
Evropska unija -
norveščina -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.